NHS postpone breakthrough £660-a-day hepatitis C drug over cost fears The NHS has faced criticism for intervening to delay the introduction of a costly but highly effective drug to combat hepatitis C. The Telegraph
See also:
See also:
- Hepatitis C drug delayed by NHS due to high cost The Guardian
No comments:
Post a Comment